---
input_text: 'Case study: Acute plasmoblastic leukemia presentation following effective
  haploidentical hematopoietic stem cell transplantation therapy. Plasma cell leukemia
  is a rare and aggressive malignancy characterized by monoclonal gammopathy and the
  presence of circulating plasma cells in the peripheral blood. Therapeutic strategies
  for plasma cell leukemia remain undefined, with treatments primarily borrowed from
  those used in multiple myeloma. The first-line treatment typically involves a combination
  of a proteasome inhibitor, an immunomodulatory agent, steroids, and/or anthracyclines
  and alkylators within an intensive chemotherapy regimen. Following this, consolidation
  with autologous hematopoietic stem cell transplantation is offered to eligible patients,
  followed by maintenance therapy. For patients ineligible for autologous hematopoietic
  stem cell transplantation, allogeneic hematopoietic stem cell transplantation is
  considered a viable alternative. Given the challenges in securing a fully human
  leukocyte antigen-matched donor, haploidentical hematopoietic stem cell transplantation
  serves as a potential salvage therapy, as demonstrated in the clinical case presented.
  This article presents the case of a female patient in her 50s diagnosed with plasma
  cell leukemia who, following unsuccessful autologous hematopoietic stem cell mobilization,
  underwent haploidentical hematopoietic stem cell transplantation from her son, resulting
  in complete donor chimerism and a favorable response.'
raw_completion_output: |-
  primary_disease: Plasma cell leukemia
  medical_actions: combination of a proteasome inhibitor, immunomodulatory agent, steroids, anthracyclines and alkylators, intensive chemotherapy regimen, consolidation with autologous hematopoietic stem cell transplantation, maintenance therapy, allogeneic hematopoietic stem cell transplantation, haploidentical hematopoietic stem cell transplantation
  symptoms: monoclonal gammopathy; circulating plasma cells in the peripheral blood
  chemicals: proteasome inhibitor; immunomodulatory agent; steroids; anthracyclines; alkylators
  action_annotation_relationships: combination of a proteasome inhibitor, immunomodulatory agent, steroids, anthracyclines and alkylators TREATS monoclonal gammopathy IN Plasma cell leukemia; combination of a proteasome inhibitor, immunomodulatory agent, steroids, anthracyclines and alkylators TREATS circulating plasma cells in the peripheral blood IN Plasma cell leukemia; consolidation with autologous hematopoietic stem cell transplantation TREATS monoclonal gammopathy IN Plasma cell leukemia; consolidation with autologous hematopoietic stem cell transplantation TREATS circulating plasma cells in the peripheral blood IN Plasma cell leukemia; allogeneic hematopoietic stem cell transplantation TREATS monoclonal gammopathy IN Plasma cell leukemia; allogeneic hematopoietic stem cell transplantation TREATS circulating plasma cells in the peripheral blood IN Plasma cell leukemia; haploidentical hematopoietic stem cell transplantation TREATS monoclonal gammopathy IN Plasma cell leukemia; haploidentical hematopoietic stem cell transplantation TREATS circulating plasma cells in the peripheral blood IN Plasma cell leukemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  haploidentical hematopoietic stem cell transplantation TREATS circulating plasma cells in the peripheral blood IN Plasma cell leukemia

  ===

extracted_object:
  primary_disease: MONDO:0018689
  medical_actions:
    - combination of a proteasome inhibitor, immunomodulatory agent, steroids, anthracyclines
      and alkylators, intensive chemotherapy regimen, consolidation with autologous
      hematopoietic stem cell transplantation, maintenance therapy, allogeneic hematopoietic
      stem cell transplantation, haploidentical hematopoietic stem cell transplantation
  symptoms:
    - HP:0031047
    - circulating plasma cells in the peripheral blood
  chemicals:
    - CHEBI:52726
    - immunomodulatory agent
    - CHEBI:35341
    - CHEBI:48120
    - alkylators
  action_annotation_relationships:
    - subject: combination of a proteasome inhibitor, immunomodulatory agent, steroids,
        anthracyclines and alkylators
      predicate: TREATS
      object: HP:0031047
      qualifier: MONDO:0018689
      subject_extension: proteasome inhibitor, immunomodulatory agent, steroids, anthracyclines,
        alkylators
    - subject: combination of a proteasome inhibitor, immunomodulatory agent, steroids,
        anthracyclines and alkylators
      predicate: TREATS
      object: circulating plasma cells in the peripheral blood
      qualifier: MONDO:0018689
      subject_extension: proteasome inhibitor, immunomodulatory agent, steroids, anthracyclines,
        alkylators
    - subject: <consolidation>
      predicate: <TREATS>
      object: <monoclonal gammopathy>
      qualifier: <Plasma cell leukemia>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <autologous hematopoietic stem cell transplantation>
      object_extension: <monoclonal gammopathy>
    - subject: consolidation
      predicate: TREATS
      object: circulating plasma cells in the peripheral blood
      qualifier: MONDO:0018689
      subject_extension: autologous hematopoietic stem cell transplantation
    - subject: MAXO:0001479
      predicate: TREATS
      object: HP:0031047
      qualifier: MONDO:0018689
      subject_extension: allogeneic hematopoietic stem cell transplantation
    - subject: MAXO:0001479
      predicate: TREATS
      object: circulating plasma cells in the peripheral blood
      qualifier: MONDO:0018689
    - subject: MAXO:0000747
      predicate: TREATS
      object: HP:0031047
      qualifier: MONDO:0018689
      subject_qualifier: haploidentical
      subject_extension: haploidentical hematopoietic stem cell transplantation
    - subject: MAXO:0000747
      predicate: TREATS
      object: plasma cells in the peripheral blood
      qualifier: MONDO:0018689
      subject_qualifier: 'NULL'
      object_qualifier: 'NULL'
      subject_extension: haploidentical
      object_extension: circulating
named_entities:
  - id: MONDO:0018874
    label: Acute myeloid leukemia (AML)
  - id: HP:0001945
    label: Fever
  - id: HP:0012378
    label: Fatigue
  - id: MONDO:0020512
    label: T cell acute lymphoblastic leukemia (T-ALL)
  - id: HP:0006727
    label: T-ALL
  - id: CHEBI:50131
    label: Decitabine
  - id: CHEBI:133021
    label: Venetoclax
  - id: HP:0004808
    label: Acute myeloid leukemia
  - id: HP:0002090
    label: pneumonia
  - id: HP:0100806
    label: sepsis
  - id: CHEBI:71019
    label: Homoharringtonine
  - id: CHEBI:28680
    label: Cytarabine
  - id: HP:0000739
    label: anxiety
  - id: HP:0000716
    label: depression
  - id: CHEBI:190514
    label: dasatinib
  - id: CHEBI:23456
    label: cyclodextrins
  - id: MAXO:0000747
    label: Hematopoietic Stem Cell Transplantation (HSCT)
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0002018
    label: Nausea
  - id: HP:0002094
    label: Dyspnea
  - id: HP:0100785
    label: Insomnia
  - id: HP:0012531
    label: Pain
  - id: HP:0002019
    label: Constipation
  - id: CHEBI:2038
    label: Azacitidine
  - id: CHEBI:197440
    label: Tumor necrosis factor-alpha (TNF-alpha)
  - id: MONDO:0004967
    label: Acute Lymphoblastic Leukemia (ALL)
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0000001
    label: Acute Lymphoblastic Leukemia (ALL)
  - id: HP:0001297
    label: Stroke
  - id: HP:0001635
    label: Heart failure
  - id: HP:0001677
    label: Coronary atherosclerosis
  - id: MONDO:0004992
    label: Cancer
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: MONDO:0004947
    label: B-cell acute lymphoblastic leukemia
  - id: MAXO:0000757
    label: infusion
  - id: MAXO:0000602
    label: Hemodialysis
  - id: HP:0003326
    label: Myalgia
  - id: HP:0002039
    label: Anorexia
  - id: HP:0100519
    label: Anuria
  - id: HP:0011037
    label: Decreased urine output
  - id: HP:0001919
    label: Acute kidney injury
  - id: CHEBI:18332
    label: Levothyroxine
  - id: MONDO:0020511
    label: Acute B-lymphoblastic leukemia (B-ALL)
  - id: HP:0003419
    label: lower back pain
  - id: MONDO:0010651
    label: high-risk myelodysplastic neoplasm (MDS)
  - id: CHEBI:30621
    label: arsenic trioxide
  - id: HP:0002360
    label: sleep disturbances
  - id: MONDO:0017361
    label: Cytokine release syndrome (CRS)
  - id: CHEBI:64360
    label: Tocilizumab
  - id: MONDO:0012883
    label: Acute promyelocytic leukemia (APL)
  - id: MAXO:0000149
    label: Allogeneic hematopoietic cell transplantation (HCT)
  - id: MONDO:0004948
    label: chronic lymphocytic leukemia
  - id: HP:0002014
    label: diarrhea
  - id: CHEBI:63791
    label: lenalidomide
  - id: HP:0005550
    label: chronic lymphocytic leukemia
  - id: MONDO:0003864
    label: Chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL)
  - id: MAXO:0001298
    label: therapies
  - id: CHEBI:42068
    label: Idarubicin
  - id: HP:0032169
    label: severe infections
  - id: CHEBI:55379
    label: cyclosporine (CsA)
  - id: CHEBI:85010
    label: eltrombopag
  - id: CHEBI:85012
    label: thrombopoietin receptor agonist (TPO-RA)
  - id: MAXO:0001394
    label: oral administration
  - id: MAXO:0001525
    label: intravenous administration
  - id: HP:0002315
    label: Headache
  - id: CHEBI:50858
    label: Corticosteroids
  - id: HP:0100614
    label: myositis
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:76612
    label: Ibrutinib
  - id: CHEBI:167707
    label: Acalabrutinib
  - id: CHEBI:145428
    label: glasdegib
  - id: MONDO:0100096
    label: COVID-19
  - id: MAXO:0010030
    label: bone marrow transplantation
  - id: HP:0001903
    label: anemia
  - id: HP:0001875
    label: neutropenia
  - id: HP:0001698
    label: pericardial effusion
  - id: CHEBI:35705
    label: immunosuppressants
  - id: MONDO:0019460
    label: Acute leukemia of ambiguous lineage (ALAL)
  - id: HP:0001873
    label: Thrombocytopenia
  - id: CHEBI:62434
    label: FLT3 inhibitor
  - id: CHEBI:38637
    label: Tyrosine kinase inhibitor
  - id: CHEBI:28748
    label: Doxorubicin (Dox)
  - id: HP:0020174
    label: drug resistance
  - id: CHEBI:23888
    label: drugs
  - id: MONDO:0018689
    label: Plasma cell leukemia
  - id: HP:0031047
    label: monoclonal gammopathy
  - id: CHEBI:52726
    label: proteasome inhibitor
  - id: CHEBI:35341
    label: steroids
  - id: CHEBI:48120
    label: anthracyclines
